Rafael Holdings, Inc. (RFL) is a company that operates in the healthcare and real estate industries. Its main business activities include investments in clinical and early-stage pharmaceutical companies, development of medical devices, and ownership of real estate assets. The company's pharmaceutical segment includes Cornerstone Pharmaceuticals, Inc., a clinical stage cancer metabolism-based therapeutics company, and LipoMedix Pharmaceuticals Ltd., a clinical stage Israeli company that develops a product candidate, Promitil. Cornerstone Pharmaceuticals...
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | CBRE | Cbre Group, Inc. | 42.12 Bn | 36.40 | 1.04 | 9.99 Bn |
| 2 | BEKE | KE Holdings Inc. | 19.37 Bn | 39.77 | 1.33 | 2.96 Bn |
| 3 | CSGP | Costar Group, Inc. | 18.57 Bn | 914.80 | 6.08 | 1.18 Bn |
| 4 | JLL | Jones Lang Lasalle Inc | 13.60 Bn | 21.53 | 0.54 | 3.48 Bn |
| 5 | FSV | FirstService Corp | 7.02 Bn | 48.37 | 1.28 | 1.38 Bn |
| 6 | CIGI | Colliers International Group Inc. | 5.59 Bn | 54.27 | 1.01 | 2.29 Bn |
| 7 | COMP | Compass, Inc. | 5.18 Bn | -91.82 | 0.78 | 0.48 Bn |
| 8 | OPEN | Opendoor Technologies Inc. | 3.12 Bn | -9.84 | 0.66 | 1.79 Bn |
| Current Valuation | Value | Ind Avg | Percentile |
|---|---|---|---|
| EV to Assets EV to Assets | -0.09 | 1.18 | |
| EV to Cash from Ops. EV/CFO | 0.43 | -6.57 | |
| EV to Debt EV to Debt | -14.62 | 5.19 | |
| EV to EBIT EV/EBIT | 0.29 | 4.86 | |
| EV to EBITDA EV/EBITDA | 0.28 | 13.56 | |
| EV to Free Cash Flow [EV/FCF] EV/FCF | 0.43 | -11.14 | |
| EV to Market Cap EV to Market Cap | -0.23 | 7.70 | |
| EV to Revenue EV/Rev | -9.44 | 3.49 | |
| Price to Book Value [P/B] P/B | 0.50 | 1.76 | |
| Price to Earnings [P/E] P/E | -1.35 | 40.59 |
| Dividend Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Dividend Coverage Ratio Dividend Coverage Ratio | 0.00 | 0.36 | |
| Dividend Payout Ratio % Div Payout % (Qtr) | 0.00 | -7.05 | |
| Dividend per Basic Share Div per Share (Qtr) | 0.00 | 0.22 | |
| FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) | 0.00 | 0.46 | |
| Interest Coverage Int. cover (Qtr) | -50.65 | -2.20 |
| Growth Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Capex Growth (1y) % Capex 1y % (Qtr) | 157.05 | -12,527.01 | |
| Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) | 458.14 | 24.62 | |
| Dividend Growth (1y) % Dividend Growth (1y) % | 0.00 | 1.26 | |
| EBIAT Growth (1y) % EBIAT 1y % (Qtr) | 22.01 | 10.86 | |
| EBITDA Growth (1y) % EBITDA 1y % (Qtr) | 66.34 | 33.08 | |
| EBIT Growth (1y) % EBIT 1y % (Qtr) | 20.96 | 19.37 | |
| EBT Growth (1y) % EBT 1y % (Qtr) | 20.18 | 28.48 | |
| EPS Growth (1y) % EPS 1y % (Qtr) | 46.99 | 29.29 | |
| FCF Growth (1y) % FCF 1y % (Qtr) | -155.11 | 67.74 | |
| Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) | 82.41 | 33.25 |
| Liquidity Ratios | Value | Ind Avg | Percentile |
|---|---|---|---|
| Asset Utilization Ratio Asset Util Ratio (Qtr) | 0.01 | 1.44 | |
| Cash Payout Ratio Cash Payout (Qtr) | 0.00 | -0.01 | |
| Cash Ratio Cash Ratio (Qtr) | 3.77 | 1.45 | |
| Current Ratio Curr Ratio (Qtr) | 4.00 | 2.16 | |
| Debt to Equity Ratio Debt/Equity (Qtr) | 0.01 | -0.07 | |
| Interest Cover Ratio Int Coverage (Qtr) | -50.65 | -2.20 | |
| Times Interest Earned Times Interest Earned (Qtr) | -50.65 | -2.20 |
| Profitability | Value | Ind Avg | Percentile |
|---|---|---|---|
| EBITDA Margin % EBITDA Margin % (Qtr) | -3,204.80 | -120.34 | |
| EBIT Margin % EBIT Margin % (Qtr) | -3,229.25 | -135.17 | |
| EBT Margin % EBT Margin % (Qtr) | -3,293.00 | -142.98 | |
| Gross Margin % Gross Margin % (Qtr) | 89.70 | 32.99 | |
| Net Profit Margin % Net Margin % (Qtr) | -3,044.70 | -138.31 |